B4392 - Genetic risk scores for increased levels of endocrine disruptors and pubertal timing - 06/10/2023

B number: 
B4392
Principal applicant name: 
Despoina Manousaki | Research Center of the CHU Sainte-Justine (Canada)
Co-applicants: 
Melody Zuo, Kaossarath Fagbemi
Title of project: 
Genetic risk scores for increased levels of endocrine disruptors and pubertal timing
Proposal summary: 

Puberty is defined as the transition from infancy to reproductive maturity characterized by the acceleration of growth velocity and the development of secondary sexual characteristics and genitals. Normal puberty onset ranges between 8-13 years old for girls, and 9-14 years old for boys. It is clinically defined as the onset of Tanner stage 2 in thelarche for girls (development of breast buds) and by Tanner stage 2 in external genitalia development for boys (increase in testicular volume to >4mL). Age at menarche in girls and age at peak height velocity in both sexes are landmarks which can be used to evaluate pubertal timing.

Endocrine disrupting chemicals (EDCs) have become increasingly prevalent in the past century as manmade products and chemicals have been made essential in our daily lives. There are nearly 85 000 human-made chemicals in the world, and 1000 or more of those could be endocrine disruptors. There are two main types of EDCs: the persistent organic compounds with decade-long half-lives such as dichloro-diphenyl-trichloroethane (DDT) in pesticides and polychlorinated biphenyls (PCBs), and those that have a shorter half-life but can cause long-term health consequences such as phthalates and bisphenol A. EDCs disrupt the body’s delicate endocrine homeostasis by acting as an agonist or antagonist when binding to hormone receptors, thereby causing unwanted effects, such as earlier timing of puberty in girls and boys. The four EDCs of interest in our study are dibutyl phthalate, bisphenol A (BPA), dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyl (PCB).

Phthalates are a large group of omnipresent compounds used as liquid plasticizers. They are found in food packaging, cosmetic products, shampoo, children’s toys and medical device tubing. It was found that first and second-trimester exposure to Bis(2-ethylhexyl) phthalate (DEHP) was associated with increased peripubertal serum estradiol levels, whereas third-trimester exposure was associated to a delay of pubarche onset. BPA is used to make polycarbonate plastic and epoxy resin. It can be found in food packaging, toys, and canned beverages’ linings. At low concentrations, BPA and other phenol compete with endogenous estrogens for binding, whereas at higher concentrations they have anti-androgenic properties.
DDT was used in many organochlorine pesticides and insecticides before being banned in 1972 in multiple countries. In 2006 however, it was reintroduced in some areas by the World Health Organization in order to fight malaria and control other vector-borne diseases. DDT exposure begins prenatally and lasts throughout a lifetime, as it is found in abundance in consumed food products, and is found to have anti-androgenic properties. PCBs were found in lubricants, electrical equipment and plasticizers up until they were banned in 1979. Studies show that childhood exposures of PCBs are associated with earlier pubertal milestones in boys, such as earlier Tanner stages.
Although a large body of evidence from observational studies exists linking EDCs to pubertal timing variations, these associations can be confounded by factors such as low socio-economic status and obesity and cannot establish causality. In the absence of evidence from randomized controlled trials- which would be unethical to employ, the causal link between EDCs and pubertal timing remains undetermined. We have generated preliminary results using two-sample Mendelian randomization for 19 EDCs, most of which do not support a causal association of genetically determined levels of these EDCs with age at menarche in girls or age at voice change or facial hair in boys. Using genetic variants associated with levels of these EDCs, which are not influenced by environmental confounders, we aim to investigate if genetic predisposition to higher levels of these chemicals could affect pubertal timing in ALSPAC children.
In the proposed project, we hypothesize that genetic risk scores (GRS) composed of one to multiple single nucleotide polymorphisms (SNPs) associated with levels of 19 endocrine disrupting chemicals (dibutyl phthalate, BPA, DDT and 16 types of PCBs) in the largest available genome-wide association studies for EDC levels, could be associated to an altered age at menarche in girls or age at peak height velocity in both girls and boys (adjusting for sex) with and without adjusting for BMI SDS at age 8 and socio-economic status.

Impact of research: 
This proposed study holds significant public health improvement potential, as, in combination of the results of our two-sample Mendelian randomization analyses, it will contribute to the understanding of the effect of EDCs on pubertal timing. EDCs are a fairly new threat to human health as they have only been on the rise in the past two centuries, therefore the health repercussions of many new chemicals have not yet been elucidated or understood. Identifying whether there are associations between specific EDCs and the hallmarks of puberty onset (age at menarche and peak height velocity) could contribute to public awareness about the consequences and inform public health policies. Additionally, taking into consideration the potential modifying effect of BMI and socio-economic status could help determine the relationship between early-life body adiposity and environment-related effects on puberty. These findings could further contribute to public health education about the importance of keeping a healthy lifestyle and a healthy BMI, especially in areas of lower socio-economic status that are more vulnerable to EDCs exposure and increased average BMI. Ultimately, the findings from this study could lead to evidence-based interventions aimed at reducing EDCs exposures during critical developmental periods in childhood, and increased awareness about the associations mediated between EDCs and puberty, which could enable better protection for the future generations and encourage other investigations on these topics.
Date proposal received: 
Friday, 4 August, 2023
Date proposal approved: 
Friday, 6 October, 2023
Keywords: 
Endocrinology, Puberty , GWAS, Endocrine - endocrine disrupters